- Feb 2, 2017
- Financial Results for the 3rd Quarter of Fiscal 2016 / Reference Data
- Jan 31, 2017
- Notice Concerning the Termination of the Agreement Between Taisho Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Co., Ltd. on the Distribution of the OTC Drugs and Quasi-Drugs of Biofermin Pharmaceutical Co., Ltd.
- Dec 26, 2016
- Notice Concerning Acquisition of Dr. Program Co., Ltd., Consolidated Subsidiary of KYORIN Holdings, Inc.
- Nov 29, 2016
- Notice of Change in Status of Major Shareholder
- Feb 3, 2017
- Presentation of Fiscal 2016 Third Quarter Results
- Oct 31, 2016
- Presentation of Fiscal 2016 Second Quarter Results